The Cost Effectiveness and Evaluation of Disease Management of Chronic Kidney Disease and High Risk Population
Chronic Kidney Diseases, Chronic Kidney Insufficiency
About this trial
This is an interventional prevention trial for Chronic Kidney Diseases focused on measuring chronic kidney disease, high risk, intervention, hypertension, hyperglycemia, hyperlipidemia
Eligibility Criteria
Inclusion Criteria:
- Age greater than 20 with chronic kidney disease (CKD) stage 1-3a patients and high-risk groups.
Exclusion Criteria:
- Inability to communicate in Chinese.
- Lack of capacity to write in Chinese.
- Ongoing treatment in dialysis.
- Suffering from major diseases.
- Treatment in cancer or suffering from cancer less than two years.
- Have received organ transplants or bone marrow transplantation.
Sites / Locations
- China Medical University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Other
Experimental
Experimental
general management
self-management
peer-assisted management
All participants received a general education with the knowledge on care for early chronic kidney disease recently establishes by the National Health Insurance system. We then used the cross-theoretical model to assess the intervention among the three groups.We collected information on baseline and follow-up data on biochemical and physiological check-ups, health promotion behavior, dietary intake status, self-efficacy and cost etc. The effectiveness assessments have been set for the baseline, 3rd, 6th, 12th and 18th months.
Participants in the self-management group are expected to emphasize on self-managed interventions, including self-monitoring and records keeping, self-education with digital video disc (DVD) courses. We negotiated their behavior change set goals for them etc.With one year of intervention period, the 3 groups will be assessed at the 18th months of follow-up next year.
The peer-assisted management group received the peer oriented group activities followed, including group discussions to share experience and sports map etc. With one year of intervention period, the 3 groups will be assessed at the 18th months of follow-up next year.